/IvermectinProphylaxis
A prophylaxis is
a measure taken to maintain health
and prevent the spread of disease.
The Indian states of Uttar Pradesh and West Bengal have officially recommended the use of Ivermectin for both prevention and treatment of COVID-19.
Dr. Allan A. Landrito (Philippines) recommends the following protocols for prophylaxis:
Argentina’s IVERCAR Ivermectin & Carrageenan Study Shows Positive Results Targeting COVID-1
https://www.biorxiv.org/content/10.1101/2020.08.19.225854v1
https://www.biorxiv.org/content/10.1101/2020.08.19.225854v1
| iota-carrageenan_and_xylitol_inhibit_sars-cov-2_in_cell_culture.pdf |
The link to a summary is:
http://www.pharmabaires.com/1739-resultados-positivos-del-protocolo-iver-car-en-la-profilaxis-de-los-agentes-de-salud.html
The link to a full protocol is at the bottom of the page.
https://www.cadenanueve.com/wp-content/uploads/2020/08/Protocolo-IVERCAR-Sinopsis-y-Resultados.pdf
http://www.pharmabaires.com/1739-resultados-positivos-del-protocolo-iver-car-en-la-profilaxis-de-los-agentes-de-salud.html
The link to a full protocol is at the bottom of the page.
https://www.cadenanueve.com/wp-content/uploads/2020/08/Protocolo-IVERCAR-Sinopsis-y-Resultados.pdf
Unpublished study:
PrePrint Version
of the same study:
of the same study:
The video below discusses the same study
as the video above.
In the video below, the discussion of
Ivermectin Prophylaxis begins at 1:31
as the video above.
In the video below, the discussion of
Ivermectin Prophylaxis begins at 1:31
The information in the video above is preliminary, and incomplete but very encouraging.
By comparison, dosages being prescribed by doctors in the United States for patients who are sick and knocking on death's door are ABSOLUTELY TINY when compared to the dosages studied for PROTECTION in healthy people in the study defined in the video above.
It is a little bit difficult to compare studies that are done in the United States with those done in other countries. Approved dosages in the United States are calculated somewhat more precisely based on the patient's actual weight.
150mcg/kg, 200mcg/kg, 400mcg/kg, etc.
Many studies done in other countries do not tailor dosages quite so precisely. Instead they set a weight range and give the same dose to everyone who falls within that weight range.
TOTAL DOSAGE GIVEN FOR PROTECTION IN THE ABOVE STUDY
Body weight in kilograms:
40-60kg - 15mg BD days 1 and 3 = 60 mg total
60-80kg - 18mg BD days 1 and 3 = 72 mg total
>80kg - 24mg BD days 1 and 3 = 96 mg total
Body weight in pounds:
88-132 pounds - 15mg BD days 1 and 3 = 60 mg total
132-176 pounds - 18mg BD days 1 and 3 = 72 mg total
>176 pounds - 24mg BD days 1 and 3 = 96 mg total
It is a little bit difficult to compare studies that are done in the United States with those done in other countries. Approved dosages in the United States are calculated somewhat more precisely based on the patient's actual weight.
150mcg/kg, 200mcg/kg, 400mcg/kg, etc.
Many studies done in other countries do not tailor dosages quite so precisely. Instead they set a weight range and give the same dose to everyone who falls within that weight range.
TOTAL DOSAGE GIVEN FOR PROTECTION IN THE ABOVE STUDY
Body weight in kilograms:
40-60kg - 15mg BD days 1 and 3 = 60 mg total
60-80kg - 18mg BD days 1 and 3 = 72 mg total
>80kg - 24mg BD days 1 and 3 = 96 mg total
Body weight in pounds:
88-132 pounds - 15mg BD days 1 and 3 = 60 mg total
132-176 pounds - 18mg BD days 1 and 3 = 72 mg total
>176 pounds - 24mg BD days 1 and 3 = 96 mg total
Example:
A U.S. doctor might give a 300 pound man and approved dose (200mcg/kg) of 27mg. If the patient was knocking on death's door, and the doctor was focused on saving his patient, rather than following protocol, then he might give another dose for a total of 54mg.
Contrast the above with the dosages used in the study in the video above that were used for prevention for caretakers who WERE NOT SICK. The study would have given a 95 pound woman who was caring for a sick relative a total of 4 doses of 15mg each for a total of 60mg. This is more than given to a dying American who is three times the caregiver's size.
A U.S. doctor might give a 300 pound man and approved dose (200mcg/kg) of 27mg. If the patient was knocking on death's door, and the doctor was focused on saving his patient, rather than following protocol, then he might give another dose for a total of 54mg.
Contrast the above with the dosages used in the study in the video above that were used for prevention for caretakers who WERE NOT SICK. The study would have given a 95 pound woman who was caring for a sick relative a total of 4 doses of 15mg each for a total of 60mg. This is more than given to a dying American who is three times the caregiver's size.
TAKE HOME MESSAGE:
U.S. doctors prescribe dosages that are SIGNIFICANTLY lower than dosages prescribed by doctors worldwide.
U.S. doctors prescribe dosages that are SIGNIFICANTLY lower than dosages prescribed by doctors worldwide.
Prophylaxis protocols are NOT a one size fits all issue. Different people have different situations and everyone is responsible for making their own decision regarding the prophylaxis protocol that is right for them.
Below are just some of the many situations:
Below are just some of the many situations:
- Frontline health care workers working directly with COVID-19 patients in intensive care units.
- Hospital workers who are in an intensive COVID-19 environment, but do not come into direct contact with patients.
- Family in-home care-givers who are caring for a loved one who has tested positive for COVID-19 but is not quarantined or hospitalized
- Essential workers in non-health related industries who come into contact with large numbers of people or handle products that may transmit fomites (grocery clerks, baristas, police officers, bus or Uber drivers, delivery persons, etc.)
- Essential workers who come into contact with a small to modest number of people (mechanics, carpenters, factory workers, etc.)
- People who work from home and live with other members of their family.
Early Action
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
https://www.sciencedirect.com/science/article/pii/S0002934320306732
https://www.sciencedirect.com/science/article/pii/S0002934320306732
